PYC Therapeutics Ltd banner

PYC Therapeutics Ltd
OTC:PYCXF

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
OTC:PYCXF
Watchlist
Price: 1.07 USD Market Closed
Market Cap: $499.3m

Wall St Price Targets

PYCXF Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYCXF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYCXF is 3.05 USD with a low forecast of 2.32 USD and a high forecast of 3.71 USD.

Lowest Forecast
Price Target
2.32 USD
116% Upside
Average Forecast
Price Target
3.05 USD
185% Upside
Highest Forecast
Price Target
3.71 USD
247% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
CFFN
Capitol Federal Financial Inc
10% Upside
SANA
Sana Biotechnology Inc
188% Upside
FULT
Fulton Financial Corp
14% Upside
CASY
Caseys General Stores Inc
-11% Downside
TTD
Trade Desk Inc
26% Upside

Revenue
Forecast

22% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
22% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 22%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PYCXF's stock price target?
Price Target
3.05 USD

According to Wall Street analysts, the average 1-year price target for PYCXF is 3.05 USD with a low forecast of 2.32 USD and a high forecast of 3.71 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett